View All Documents & Correspondence
Ophthalmic Compositions
Abstract: The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II, formula III, formula IV, formula V, formula VI, formula VII, formula VIII, formula IX, formula X, formula XI formula XII, formula XIII, formula XIV, formula XV, formula XVI, or formula XVII and the methods for the treatment of eye diseases may be formulated for topical eye drop, topical paste, ocular solution, device-drug delivery, oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, nasal spray, oral solution, suspension, oral spray, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of glaucoma, presbyopia, IOP, cataract, dry eye and oGVHD.
Notices, Deadlines & Correspondence
Patent Information
Applicants
CELLIX BIO PRIVATE LIMITED
Inventors
1. KANDULA, Mahesh
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202147002301-STATEMENT OF UNDERTAKING (FORM 3) [18-01-2021(online)].pdf | 2021-01-18 |
| 2 | 202147002301-PROOF OF RIGHT [18-01-2021(online)].pdf | 2021-01-18 |
| 3 | 202147002301-PRIORITY DOCUMENTS [18-01-2021(online)].pdf | 2021-01-18 |
| 4 | 202147002301-POWER OF AUTHORITY [18-01-2021(online)].pdf | 2021-01-18 |
| 5 | 202147002301-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105) [18-01-2021(online)].pdf | 2021-01-18 |
| 6 | 202147002301-FORM FOR SMALL ENTITY(FORM-28) [18-01-2021(online)].pdf | 2021-01-18 |
| 7 | 202147002301-FORM 1 [18-01-2021(online)].pdf | 2021-01-18 |
| 8 | 202147002301-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [18-01-2021(online)].pdf | 2021-01-18 |
| 9 | 202147002301-DECLARATION OF INVENTORSHIP (FORM 5) [18-01-2021(online)].pdf | 2021-01-18 |
| 10 | 202147002301-COMPLETE SPECIFICATION [18-01-2021(online)].pdf | 2021-01-18 |
| 11 | 202147002301-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [18-01-2021(online)].pdf | 2021-01-18 |
| 12 | 202147002301-Correspondence_Form1, Power of Attorney_27-01-2021.pdf | 2021-01-27 |
| 13 | 202147002301-FORM 3 [03-07-2021(online)].pdf | 2021-07-03 |
| 14 | 202147002301.pdf | 2021-10-18 |
| 15 | 202147002301-FORM 3 [19-04-2022(online)].pdf | 2022-04-19 |
| 16 | 202147002301-FORM 18 [07-06-2022(online)].pdf | 2022-06-07 |
| 17 | 202147002301-FER.pdf | 2022-07-20 |
| 18 | 202147002301-RELEVANT DOCUMENTS [22-11-2022(online)].pdf | 2022-11-22 |
| 19 | 202147002301-POA [22-11-2022(online)].pdf | 2022-11-22 |
| 20 | 202147002301-FORM 13 [22-11-2022(online)].pdf | 2022-11-22 |
| 21 | 202147002301-OTHERS [19-01-2023(online)].pdf | 2023-01-19 |
| 22 | 202147002301-Information under section 8(2) [19-01-2023(online)].pdf | 2023-01-19 |
| 23 | 202147002301-FORM 3 [19-01-2023(online)].pdf | 2023-01-19 |
| 24 | 202147002301-FER_SER_REPLY [19-01-2023(online)].pdf | 2023-01-19 |
| 25 | 202147002301-CORRESPONDENCE [19-01-2023(online)].pdf | 2023-01-19 |
| 26 | 202147002301-CLAIMS [19-01-2023(online)].pdf | 2023-01-19 |
| 27 | 202147002301-US(14)-HearingNotice-(HearingDate-21-06-2023).pdf | 2023-05-23 |
| 28 | 202147002301-FORM-26 [23-06-2023(online)].pdf | 2023-06-23 |
| 29 | 202147002301-Correspondence to notify the Controller [23-06-2023(online)].pdf | 2023-06-23 |
| 30 | 202147002301-PatentCertificate12-07-2023.pdf | 2023-07-12 |
| 31 | 202147002301-IntimationOfGrant12-07-2023.pdf | 2023-07-12 |
Search Strategy
| 1 | SearchHistory(91)E_19-07-2022.pdf |